Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

Clinical trial NCT00914940 · TERMINATED

Trial details

NCT number: NCT00914940
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Leukemia Myelodysplastic Syndromes

Start date: 2009-12-17
Primary completion: 2019-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.